Cargando…
Metabolic Response of Pancreatic Carcinoma Cells under Treatment with Dichloroacetate
In modern oncology, the analysis and evaluation of treatment response are still challenging. Hence, we used a (13)C-guided approach to study the impacts of the small molecule dichloroacetate (DCA) upon the metabolic response of pancreatic cancer cells. Two different oncogenic PI3K-driven pancreatic...
Autores principales: | Feuerecker, Benedikt, Biechl, Philipp, Veltkamp, Christian, Saur, Dieter, Eisenreich, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228235/ https://www.ncbi.nlm.nih.gov/pubmed/34070873 http://dx.doi.org/10.3390/metabo11060350 |
Ejemplares similares
-
Diverse metabolic response of cancer cells treated with a (213)Bi-anti-EGFR-immunoconjugate
por: Feuerecker, Benedikt, et al.
Publicado: (2021) -
Diverse Roads Taken by (13)C-Glucose-Derived Metabolites in Breast Cancer Cells Exposed to Limiting Glucose and Glutamine Conditions
por: Gkiouli, Maria, et al.
Publicado: (2019) -
Anaerobic Microbial Metabolism of Dichloroacetate
por: Chen, Gao, et al.
Publicado: (2021) -
MTOR inhibitor-based combination therapies for pancreatic cancer
por: Hassan, Zonera, et al.
Publicado: (2018) -
Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models
por: Neveu, Marie-Aline, et al.
Publicado: (2016)